TP53 and neuroendocrine carcinoma: Abnormal p53 expression has also been reported in poorly differentiated neuroendocrine carcinomas (NECs), correlating with aggressive behavior and poorer prognosis, whereas well-differentiated NETs typically retain normal p53 expression (45, 46).